Research Paper Volume 15, Issue 18 pp 9633—9660
A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Figure 1. Gefitinib could inhibit cancer cell growth and migration. (A–C) Cell viability; (D) Cell apoptosis; (E) Cell Migration; (F) Cell Invasion.